Until recently, the opportunity to have a celebrity attend an event, attach themselves to a name-brand or endorse a certain product or idea was untouchable. The thought of paying a person to promote a product was seen as something only Fortune 500 companies could afford. Social media has changed all that with brands and businesses utilizing celebrity influencers to connect directly with their demographics and increase sales and profits.
AUTUMN PHARMACCES LEADERS FORUM
Event contact first name
Event contact last name
Event contact telephone number
+421 2 3266 0382
Various options and decision-making tools exist, some old, some novel. Traditional decision making based on, for example, price referencing, DRGs budgets or generic substitution are still significant. However, recent advances in the sophistication of HTA analysis and modeling, flexible pay for performance models, risk-sharing and value-based pricing schemes have become increasingly important to mitigate payer risk and allocate financial resources to the areas of pressing need. Savings and outcome improvements can also be found through finding efficiency gains at the healthcare delivery level, providing the right incentives for prescribers and improving patient adherence. 3 EVENTS IN ONE: 1. International Pharmaceutical Payers & HTA Summit 2. Among Action: Experiences With the German Pharmaceutical Pricing & Reimbursement Reform 3. Market Access for High Value Speciality & Biologic Medicines Request agenda at http://bigdata2014.nextlevelpharma.com/request-agenda .